PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDTY.L Regulatory News (DTY)

  • There is currently no data for DTY

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI)- Replacement of Dignity plc

21 Apr 2023 14:21

RNS Number : 1041X
Morgan Stanley & Co. Int'l plc
21 April 2023
 

AMENDMENT(2(a))

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Morgan Stanley & Co. International plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Dignity plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Valderrama Limited

(d) Date dealing undertaken:

19 April 2023

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

12 48/143p ordinary

PURCHASES

50,091

5.5048 GBP

5.4900 GBP

12 48/143p ordinary

SALES

50,516

5.5062 GBP

5.5000 GBP

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

12 48/143p ordinary

CFD

reducing a short position

71

5.5000 GBP

12 48/143p ordinary

CFD

reducing a short position

287

5.5000 GBP

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

N/A

N/A

N/A

N/A

N/A

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

N/A

N/A

N/A

N/A

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

NONE

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

NONE

 

 

 

Date of disclosure:

21 April 2023

Contact name:

Craig Horsley

Telephone number:

+44 141 245-7736

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERXFLFLXZLFBBK
Date   Source Headline
9th Jun 201711:36 amRNSResults of AGM
31st May 20172:06 pmRNSVoting Rights and Capital
19th May 20172:10 pmRNSBlock listing Interim Review
17th May 20174:38 pmRNSDirector/PDMR Shareholding
15th May 20174:35 pmRNSDirector/PDMR Shareholding
15th May 20177:00 amRNSFirst quarter trading update
28th Apr 20179:08 amRNSVoting Rights and Capital
27th Apr 20177:00 amRNSNotification of Q1 Trading Update
13th Apr 20175:11 pmRNSDirector/PDMR Shareholding
13th Apr 201711:03 amRNSRelease of the 2016 Annual Report
12th Apr 20171:09 pmRNSDirector/PDMR Shareholding
7th Apr 20175:51 pmRNSDirector/PDMR Shareholding
5th Apr 20171:00 pmRNSDirector/PDMR Shareholding
5th Apr 201712:10 pmRNSDirector/PDMR Shareholding
31st Mar 201710:19 amRNSVoting Rights and Capital
21st Mar 20173:06 pmRNSDirector Declaration
16th Mar 20171:57 pmRNSDirector(s)/PDMR Shareholding
13th Mar 20173:30 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
9th Mar 20174:55 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
8th Mar 20177:00 amRNSPreliminary Results
1st Mar 20174:44 pmRNSAdditional Listing
28th Feb 20174:20 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
28th Feb 201710:40 amRNSVoting Rights and Capital
13th Feb 20171:00 pmRNSDirectorate Change
8th Feb 20179:45 amRNSNotification of Preliminary Results
7th Feb 20174:46 pmRNSDirectorate Change
31st Jan 201710:50 amRNSVoting Rights and Capital
9th Jan 20173:35 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
30th Dec 201611:43 amRNSVoting Rights and Capital
13th Dec 20165:10 pmRNSDirector/PDMR Shareholding
30th Nov 20168:35 amRNSBlock listing Interim Review
17th Nov 201611:41 amRNSAdditional Listing
7th Nov 20167:00 amRNSThird quarter trading update
4th Nov 20162:45 pmRNSNon-Executive Director Change
31st Oct 20169:45 amRNSVoting Rights and Capital
30th Sep 201610:45 amRNSVoting Rights and Capital
15th Sep 20169:48 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
31st Aug 201610:45 amRNSVoting Rights and Capital
17th Aug 20169:06 amRNSBlock listing Interim Review
16th Aug 201612:40 pmRNSBlock listing Interim Review
9th Aug 201612:36 pmRNSReplacement - Director/PDMR Shareholding
9th Aug 201610:45 amRNSDirector/PDMR Shareholding
9th Aug 201610:45 amRNSDirector/PDMR Shareholding
9th Aug 201610:45 amRNSDirector/PDMR Shareholding
27th Jul 20167:00 amRNSInterim Results
28th Jun 20167:00 amRNSCompletion of acquisition of three crematoria
27th Jun 20169:30 amRNSNotification of Interim Results
17th Jun 20164:48 pmRNSDirector/PDMR Shareholding
16th Jun 20162:39 pmRNSDirector/PDMR Shareholding
10th Jun 20162:15 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.